Orexigen (OREX) in Focus: Stock Moves 6.1% Higher

Orexigen Therapeutics, Inc. (OREX) was a big mover last session with its shares rising over 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company as the stock is now trading above the past one month’s volatile price range of $5.29 to $5.90.

This biopharmaceutical company has seen has seen no estimate revision in the last 7 days. The Zacks Consensus Estimate hasn’t been in trend either. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Orexigen currently holds a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

Investors interested in the broader medical sector may consider other well-placed stocks like Myriad Genetics Inc. (MYGN), Gilead Sciences Inc. (GILD) and Illumina Inc. (ILMN). All three stocks sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>




OREXIGEN THERAPEUTICS INC (OREX): Free Stock Analysis Report

MYRIAD GENETICS INC (MYGN): Free Stock Analysis Report

GILEAD SCIENCES INC (GILD): Free Stock Analysis Report

ILLUMINA INC (ILMN): Free Stock Analysis Report


Zacks Investment Research

Advertisement